Hardik Parikh
Stock Analyst at JP Morgan
(n/a)
# 4,740
Out of 5,114 analysts
6
Total ratings
n/a
Success rate
-44.57%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Hardik Parikh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GPCR Structure Therapeutics | Maintains: Overweight | $65 → $105 | $87.15 | +20.48% | 2 | Jan 22, 2026 | |
| VKTX Viking Therapeutics | Maintains: Overweight | $80 → $75 | $30.24 | +148.02% | 2 | Oct 24, 2025 | |
| PCRX Pacira BioSciences | Downgrades: Underweight | $45 → $10 | $20.09 | -50.22% | 2 | Aug 12, 2024 |
Structure Therapeutics
Jan 22, 2026
Maintains: Overweight
Price Target: $65 → $105
Current: $87.15
Upside: +20.48%
Viking Therapeutics
Oct 24, 2025
Maintains: Overweight
Price Target: $80 → $75
Current: $30.24
Upside: +148.02%
Pacira BioSciences
Aug 12, 2024
Downgrades: Underweight
Price Target: $45 → $10
Current: $20.09
Upside: -50.22%